Form 13-F position report

BIOGEN INC

Reported by D E Shaw & Co Inc

BIIB CUSIP 09062X103 Manager CIK 0001009207

Reported 1,366,207 shares, down 219,365 (13.8%) from the prior quarter.

Reported value -20.9%; share count -13.8% vs. the prior quarter.

Reduced
% of reported 13F value 0.12% This manager · Q2 2025
Shares 1,366,207 Quarter-end amount reported
Reported value $171,581,937 Fair value at quarter end
Consecutive quarters held 49 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 143222000
2022-03-31 209312000
2022-06-30 276513000
2022-09-30 409929000
2022-12-31 486294227
2023-03-31 370889239
2023-06-30 241109574
2023-09-30 71664155
2023-12-31 6193660
2024-03-31 64690725
2024-06-30 49769668
2024-09-30 84308576
2024-12-31 246185755
2025-03-31 216969673
2025-06-30 171581937
2025-09-30 66947594
2025-12-31 9460166
2026-03-31 0
2026-06-30 16083074
2026-09-30 15110694

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for BIOGEN INC held by D E Shaw & Co Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 66,897 -7,541 (-10.1%) < 0.01% $15,110,694 2026-11-16
Q2 2026 New 74,438 +74,438 (0.0%) < 0.01% $16,083,074 2026-08-14
Q1 2026 Reduced 0 -53,754 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 53,754 -424,170 (-88.8%) < 0.01% $9,460,166 2026-02-17
Q3 2025 Reduced 477,924 -888,283 (-65.0%) 0.04% $66,947,594 2025-11-14
Q2 2025 Reduced 1,366,207 -219,365 (-13.8%) 0.12% $171,581,937 2025-08-14
Q1 2025 Reduced 1,585,572 -24,327 (-1.5%) 0.19% $216,969,673 2025-05-15
Q4 2024 Added 1,609,899 +1,174,960 (270.1%) 0.18% $246,185,755 2025-02-14
Q3 2024 Added 434,939 +220,248 (102.6%) 0.07% $84,308,576 2024-11-14
Q2 2024 Reduced 214,691 -85,317 (-28.4%) 0.05% $49,769,668 2024-08-14
Q1 2024 Added 300,008 +276,073 (1153.4%) 0.06% $64,690,725 2024-05-15
Q4 2023 Reduced 23,935 -254,903 (-91.4%) < 0.01% $6,193,660 2024-02-14
Q3 2023 Reduced 278,838 -567,606 (-67.1%) 0.07% $71,664,155 2023-11-14
Q2 2023 Reduced 846,444 -487,546 (-36.5%) 0.25% $241,109,574 2023-08-14
Q1 2023 Reduced 1,333,990 -422,092 (-24.0%) 0.4% $370,889,239 2023-05-15
Q4 2022 Added 1,756,082 +220,767 (14.4%) 0.54% $486,294,227 2023-02-14
Q3 2022 Added 1,535,315 +179,461 (13.2%) 0.49% $409,929,000 2022-11-14
Q2 2022 Added 1,355,854 +361,974 (36.4%) 0.32% $276,513,000 2022-08-15
Q1 2022 Added 993,880 +396,919 (66.5%) 0.2% $209,312,000 2022-05-16
Q4 2021 Added 596,961 +220,470 (58.6%) 0.12% $143,222,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

969 managers reported BIOGEN INC for Q2 2025.

Managers reporting BIOGEN INC in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 17,290,651 +257,812 0.04% $2,171,532,858 49 qtrs
PRIMECAP MANAGEMENT CO CA Reduced 15,802,122 -141,137 1.57% $1,984,588,503 49 qtrs
BlackRock Inc Reduced 13,555,466 -1,655,570 0.03% $1,702,431,056 4 qtrs
STATE STREET CORPORATION Added 7,468,807 +71,897 0.04% $938,007,471 49 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 4,798,420 +125,983 0.11% $602,633,568 49 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 3,918,150 +71,286 0.03% $490,089,204 49 qtrs
Point72 Asset Management L P Added 3,831,727 +3,424,470 0.94% $481,226,574 2 qtrs
Invesco Ltd Added 2,320,126 +55,119 0.05% $291,384,624 49 qtrs
NORGES BANK Added 2,264,177 +110,791 0.04% $284,357,989 49 qtrs
MORGAN STANLEY Reduced 1,956,210 -34,458 0.02% $245,680,815 49 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 14, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,346,607
Shared
0
None
19,600

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.